SUPPORTIVE CARE / SYMPTOM MANAGEMENT RESEARCH

About Supportive Care/Symptom Management Research

Supportive care research includes the primary and tertiary prevention of both prevention and treatment associated morbidities. This includes research on the management of acute symptoms related to cancer and its active treatment during the treatment phase and at the end of life. This research may be qualitative or quantitative and include physiologic as well as behavioral variables.

Introduction, application and evaluation of effective and practical interventions for supportive care, symptom management.
Evaluation of care delivery systems for symptom management.
Evaluation of symptom management therapies, e.g. pain, fatigue, physiologic and psychosocial symptoms during tumor-directed therapies or at the end of life.
Prevention of adverse reactions, physical and psychosocial, including effects on quality of life and short and long-term sequelae where the intervention is delivered during treatment or prevention activities.
Prevention of toxicities associated with prevention and curative therapies.
Development of techniques to maintain and restore physical and psychosocial functioning during treatment.
Evaluation of the impact of different care delivery sites on patient and care-giver quality of life, morbidity and survival. Delivery sites may include the home, community-based settings, or other non-traditional care locations.

End of life care includes research related to the experience of dying: quality of life at the end of life, symptom management at the end of life, and environmental and social influences on the experience of dying.

	SUPPORTIVE CARE / SYMPTOM MANAGEMENT RESEARCH About Supportive Care/Symptom Management Research Supportive care research includes the primary and tertiary prevention of both prevention and treatment associated morbidities. This includes research on the management of acute symptoms related to cancer and its active treatment during the treatment phase and at the end of life. This research may be qualitative or quantitative and include physiologic as well as behavioral variables. Introduction, application and evaluation of effective and practical interventions for supportive care, symptom management. Evaluation of care delivery systems for symptom management. Evaluation of symptom management therapies, e.g. pain, fatigue, physiologic and psychosocial symptoms during tumor-directed therapies or at the end of life. Prevention of adverse reactions, physical and psychosocial, including effects on quality of life and short and long-term sequelae where the intervention is delivered during treatment or prevention activities. Prevention of toxicities associated with prevention and curative therapies. Development of techniques to maintain and restore physical and psychosocial functioning during treatment. Evaluation of the impact of different care delivery sites on patient and care-giver quality of life, morbidity and survival. Delivery sites may include the home, community-based settings, or other non-traditional care locations. End of life care includes research related to the experience of dying: quality of life at the end of life, symptom management at the end of life, and environmental and social influences on the experience of dying.



HOME \| DICTIONARY \| SITE MAP \| SEARCH ACCESSIBILITY \| PRIVACY POLICY \| CONTACT DCP